Drug Reference

Codeine / Ibuprofen

Opioids in combination with non-opioid analgesics

← All medicines · Opioids in combination with non-opioid analgesics

Pediatric contraindication

Fact box

Therapeutic class
Opioids in combination with non-opioid analgesics

Available as

12.5 MG · Oral Tablet12.8 MG · Oral Tablet20 MG · Extended Release Oral Tablet
Multi-ingredient product
CodeineIbuprofen

This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.

Pediatric use

Pediatric contraindication

Contraindicated for pain or cough in children <12 years; carries an FDA boxed warning. Also contraindicated in children <18 after tonsillectomy/adenoidectomy and in adolescents 12–18 who are obese or have OSA/respiratory compromise, due to ultra-rapid metabolism and fatal respiratory depression.

Source: FDA Drug Safety Communication 2017; codeine prescribing information (boxed warning).

⚑ About half of pediatric medication use is off-label and not described in FDA labels — absence of pediatric information does not mean a medicine is unused or unsafe in children. Confirm with your clinician.

3 marketed products on record (RxNorm)

Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.